1-2 of 2
Shinichi Kitada, Ph.D.
Close
Sort by
Journal Articles

BCL2 Splice Isoform Switching Promotes Leukemia Stem Cell Survival and Sensitivity to a Novel Pan BCL2 Inhibitor

Daniel Goff, BS, Kristen M Smith, Ph.D., Alice Y Shih, BS, Angela Court-Recart, MS, Anil Sadarangani, Ph.D., Ifat Geron, MSc, Ryan Chuang, Larisa Balaian, Ph.D., Jun Wei, Ph.D., Shinichi Kitada, Ph.D., Dayong Zhai, Ph.D., Jason Gotlib, MD, MS, Mark D. Minden, MD, PhD, Giovanni Martinelli, MD, Annelie Schairer, Ph.D., Heather Leu, BS, Wenxue Ma, MD, PhD, Qingfei Jiang, Ph.D., Jessica Rusert, B.S., Kim-Hien T Dao, D.O., Ph.D., Kamran Shazand, PhD, Milica Volar, Richard de Borja, John D McPherson, PhD, Thomas J Hudson, MD, Christian L Barrett, Ph.D., Kelly A Frazer, Ph.D., Peggy Wentworth, Ph.D., Christina Jamieson, Ph.D., Sheldon R Morris, MD, MPH, Lawrence S. B. Goldstein, Ph.D., Maurizio Pellechia, Ph.D., John C. Reed, MD, PhD, Catriona Jamieson
Journal: Blood
Blood (2011) 118 (21): 2735.
https://doi.org/10.1182/blood.V118.21.2735.2735
Published: 2011
Journal Articles

Increased Incidence of Therapy Related Myeloid Neoplasia (t-MN) After Initial Therapy for CLL with Fludarabine-Cyclophosphamide (FC) Vs Fludarabine (F): Long-Term Follow-up of US Intergroup Study E2997

Mitchell R Smith, MD, PhD, Donna Neuberg, ScD, Ian W. Flinn, MD, PhD, Michael R. Grever, M.D., John M. Bennett, MD, Gordon Dewald, Elisabeth M Paietta, PhD, Mark R. Litzow, MD, Jacob M. Rowe, David Lucas, PhD, Shinichi Kitada, Ph.D., Diane F. Jelinek, PhD, John G. Gribben, MD, DSc, John C. Byrd, MD, John C. Reed, MD, PhD, Mohamad A. Hussein, M.D., Frederick R. Appelbaum, MD, Richard A. Larson, MD, Dennis F Moore, Jr, MD, Martin S. Tallman, MD
Journal: Blood
Blood (2010) 116 (21): 924.
https://doi.org/10.1182/blood.V116.21.924.924
Published: 2010